Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
Gemer O, Lavie O, Gdalevich M, Eitan R, Mamanov E, Piura B, Rabinovich A, Levavi H, Saar-Ryss B, Halperin R, Finci S, Beller U, Bruchim I, Levy T, Meirovitz A, Shachar IB, Arie AB.
Gemer O, et al. Among authors: piura b.
Am J Clin Oncol. 2016 Feb;39(1):37-42. doi: 10.1097/COC.0000000000000011.
Am J Clin Oncol. 2016.
PMID: 25734407